RESUMO
BackgroundCurrent strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are limited to non-pharmacological interventions. Hydroxychloroquine (HCQ) has been proposed as a postexposure therapy to prevent Coronavirus disease 2019 (Covid-19) but definitive evidence is lacking. MethodsWe conducted an open-label, cluster-randomized trial including asymptomatic contacts exposed to a PCR-positive Covid-19 case in Catalonia, Spain. Clusters were randomized to receive no specific therapy (control arm) or HCQ 800mg once, followed by 400mg daily for 6 days (intervention arm). The primary outcome was PCR-confirmed symptomatic Covid-19 within 14 days. The secondary outcome was SARS-CoV-2 infection, either symptomatically compatible or a PCR-positive result regardless of symptoms. Adverse events (AEs) were assessed up to 28 days. ResultsThe analysis included 2,314 healthy contacts of 672 Covid-19 index cases identified between Mar 17 and Apr 28, 2020. A total of 1,198 were randomly allocated to usual care and 1,116 to HCQ therapy. There was no significant difference in the primary outcome of PCR-confirmed, symptomatic Covid-19 disease (6.2% usual care vs. 5.7% HCQ; risk ratio 0.89 [95% confidence interval 0.54-1.46]), nor evidence of beneficial effects on prevention of SARS-CoV-2 transmission (17.8% usual care vs. 18.7% HCQ). The incidence of AEs was higher in the intervention arm than in the control arm (5.9% usual care vs 51.6% HCQ), but no treatment-related serious AEs were reported. ConclusionsPostexposure therapy with HCQ did not prevent SARS-CoV-2 disease and infection in healthy individuals exposed to a PCR-positive case. Our findings do not support HCQ as postexposure prophylaxis for Covid-19. ClinicalTrials.gov registration numberNCT04304053
Assuntos
Doenças Autoimunes/epidemiologia , Big Data , Feminino , Humanos , Masculino , Prevalência , Espanha/epidemiologiaRESUMO
In this work, a natural zeolite, modified and loaded with iron (NZ-A-Fe) as a heterogeneous catalyst, was characterized for its suitability as a permeable reactive barrier (PRB) material for treatment of aromatic hydrocarbons in groundwater. Adsorption and oxidation processes were analyzed. Batch adsorption tests for benzene, toluene and xylene (BTX) aqueous concentrated solutions were performed at neutral pH. Kinetic adsorption was described with the pseudo-second-order model. Experiments were performed using a stirred batch reactor with near 11 mM initial BTX concentration applying NZ-A-Fe as solid catalyst and H2O2 as an oxidant. BTX removal reached 80% in 600 min in these experimental conditions. Catalytic oxidation was described with a pseudo-first-order kinetic model. No significant iron leaching was detected during all the experiences. These investigations show that coupling adsorption with catalytic oxidation with this novel system is a promising procedure to simultaneously remove BTX from moderately concentrated aqueous solution at neutral pH in groundwater.
Assuntos
Benzeno/química , Ferro/química , Tolueno/química , Poluentes Químicos da Água/química , Purificação da Água/métodos , Xilenos/química , Zeolitas/química , Adsorção , Catálise , Água Subterrânea/química , Peróxido de Hidrogênio/química , Concentração de Íons de Hidrogênio , Cinética , OxirreduçãoRESUMO
There are limitations in our capacity to interpret point estimates and trends of infectious diseases occurring among diverse migrant populations living in the European Union/European Economic Area (EU/EEA). The aim of this study was to design a data collection framework that could capture information on factors associated with increased risk to infectious diseases in migrant populations in the EU/EEA. The authors defined factors associated with increased risk according to a multi-dimensional framework and performed a systematic literature review in order to identify whether those factors well reflected the reported risk factors for infectious disease in these populations. Following this, the feasibility of applying this framework to relevant available EU/EEA data sources was assessed. The proposed multidimensional framework is well suited to capture the complexity and concurrence of these risk factors and in principle applicable in the EU/EEA. The authors conclude that adopting a multi-dimensional framework to monitor infectious diseases could favor the disaggregated collection and analysis of migrant health data.